title: Conversion of rheumatic atrial fibrillation by amiodarone after percutaneous balloon mitral commissurotomy.
abstract: Amiodarone, used in conjunction with percutaneous balloon mitral commissurotomy, can safely convert rheumatic atrial fibrillation in 38% of patients compared with 0% in those without it. However, whether this treatment exerts long-term benefits on prognosis awaits further investigation.
authors: Division of Cardiology, Department of Medicine, Taichung Veterans General Hospital, Taipei, Taiwan. trliu@vghtc.vghtc.gov.tw
authors: Tsun-Jui
authors: TJ
authors: Liu
authors: Chung-Whei
authors: CW
authors: Hsueh
authors: Wen-Lieng
authors: WL
authors: Lee
authors: Hui-Chin
authors: HC
authors: Lai
authors: Kuo-Yang
authors: KY
authors: Wang
authors: Chih-Tai
authors: CT
authors: Ting
mesh_terms: D000638:Amiodarone / Q000009:adverse effects / Q000627:therapeutic use*; D000889:Anti-Arrhythmia Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000188:drug therapy* / Q000209:etiology; D002404:Catheterization; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D008946:Mitral Valve Stenosis / Q000209:etiology / Q000601:surgery*; D011446:Prospective Studies; D012214:Rheumatic Heart Disease / Q000150:complications / Q000628:therapy*
chemical_list: D000889:Anti-Arrhythmia Agents; D000638:Amiodarone